Photocure to Present at Two Upcoming Investor Conferences in June 2021
Photocure to Present at Two Upcoming Investor Conferences in June 2021 - read this article along with other careers information, tips and advice on BioSpace
Stay updated with breaking news from Company Codes. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Photocure to Present at Two Upcoming Investor Conferences in June 2021 - read this article along with other careers information, tips and advice on BioSpace
Additional provincial coverage expected to follow MONTREAL, April 28, 2021 /PRNewswire/ - Valeo Pharma Inc. (CSE: VPH) (OTCQB: VPHIF) (FSE: VP2) (" Valeo" or the " Company"), a Canadian pharmaceutical company, today announced that it has entered into a Product Listing Agreement ("PLA") with the Executive Officer of the Ontario Public Drug Program for the listing of Redesca ® and Redesca HP ®, its low molecular weight heparin ("LMWH") biosimilar, on the Ontario Drug Benefit Formulary effective April 30, 2021. "With Ontario representing 37% of the Canadian market for LMWHs, the listin...
[This unedited press release is made available courtesy of Gamasutra and its partnership with notable game PR-related resource Games Press.] [21-April-2021] AALBORG, Denmark, April 21, 2021 /PRNewswire/ -- Asetek, the creator of the all-in-one liquid cooler and the global leader in liquid cooling solutions for gaming PCs and DIY enthusiasts, announced that ASUS has introduced the second generation of ROG Ryujin all-in-one CPU coolers for high-end builds, leveraging the superior thermal and acoustic performance and reliability associated with Asetek's most advanced liqu...
with Confirmed COVID-19 Illness TORONTO, April 1, 2021 /PRNewswire/ - SQI Diagnostics Inc. (the "Company" or "SQI") (TSXV: SQD) (OTCQB: SQIDF), a precision medicine company that discovers, develops and commercializes innovative rapid diagnostic testing for healthcare professionals, patients and consumers worldwide, announces that it has submitted its fully completed clinical and analytical data package to the U.S. Food and Drug Administration (FDA) for emergency use authorization (EUA) of its RALI-Dx ™ IL-6 Severity Triage Test. The submission was completed on March 31, 2021. The FDA wi...
CTI BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Mar 09, 2021 - read this article along with other careers information, tips and advice on BioSpace